119 related articles for article (PubMed ID: 10387964)
1. Intraperitoneal Therapy of Ovarian Cancer.
Markman M
Oncologist; 1996; 1(1 & 2):18-21. PubMed ID: 10387964
[TBL] [Abstract][Full Text] [Related]
2. Intraperitoneal chemotherapy in the management of malignant disease.
Markman M
Expert Rev Anticancer Ther; 2001 Jun; 1(1):142-8. PubMed ID: 12113122
[TBL] [Abstract][Full Text] [Related]
3. Current status of intraperitoneal therapy for ovarian cancer.
Markman M
Curr Opin Obstet Gynecol; 1993 Feb; 5(1):99-104. PubMed ID: 7678757
[TBL] [Abstract][Full Text] [Related]
4. Salvage therapy in ovarian cancer: is there a role for intraperitoneal drug delivery?
Markman M
Gynecol Oncol; 1993 Oct; 51(1):86-9. PubMed ID: 8244180
[TBL] [Abstract][Full Text] [Related]
5. Evidence supporting the superiority of intraperitoneal cisplatin compared to intraperitoneal carboplatin for salvage therapy of small-volume residual ovarian cancer.
Markman M; Reichman B; Hakes T; Rubin S; Lewis JL; Jones W; Barakat R; Curtin J; Almadrones L; Hoskins W
Gynecol Oncol; 1993 Jul; 50(1):100-4. PubMed ID: 8349150
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
7. Medical therapy of advanced malignant epithelial tumours of the ovary.
Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
[TBL] [Abstract][Full Text] [Related]
8. Intraperitoneal therapy of ovarian cancer.
Markman M
Semin Oncol; 1998 Jun; 25(3):356-60. PubMed ID: 9633848
[TBL] [Abstract][Full Text] [Related]
9. Antineoplastic agents in the management of ovarian cancer: current status and emerging therapeutic strategies.
Markman M
Trends Pharmacol Sci; 2008 Oct; 29(10):515-9. PubMed ID: 18760845
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of combination intraperitoneal cisplatin and 5-fluorouracil in previously treated patients with advanced ovarian cancer: long-term follow-up.
Morgan RJ; Braly P; Leong L; Shibata S; Margolin K; Somlo G; McNamara M; Longmate J; Schinke S; Raschko J; Nagasawa S; Kogut N; Najera L; Johnson D; Doroshow JH
Gynecol Oncol; 2000 Jun; 77(3):433-8. PubMed ID: 10831355
[TBL] [Abstract][Full Text] [Related]
11. Role of intraperitoneal chemotherapy in the front-line setting.
Markman M
J Clin Oncol; 2003 May; 21(10 Suppl):145s-148s. PubMed ID: 12743130
[TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal interferon-alpha in residual ovarian carcinoma: a phase II gynecologic oncology group study.
Berek JS; Markman M; Stonebraker B; Lentz SS; Adelson MD; DeGeest K; Moore D
Gynecol Oncol; 1999 Oct; 75(1):10-4. PubMed ID: 10502418
[TBL] [Abstract][Full Text] [Related]
13. An update on the use of intraperitoneal chemotherapy in the management of ovarian cancer.
Markman M
Cancer J; 2009; 15(2):105-9. PubMed ID: 19390303
[TBL] [Abstract][Full Text] [Related]
14. [Intraperitoneal chemotherapy in ovarian carcinoma].
Piura B
Harefuah; 2001 Sep; 140(9):844-9, 894, 893. PubMed ID: 11579736
[TBL] [Abstract][Full Text] [Related]
15. The Challenge of Developing New Therapies for Childhood Cancers.
Balis FM
Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
[TBL] [Abstract][Full Text] [Related]
16. Intraperitoneal cisplatin chemotherapy in the management of ovarian carcinoma.
Markman M
Semin Oncol; 1989 Aug; 16(4 Suppl 6):79-82. PubMed ID: 2669140
[TBL] [Abstract][Full Text] [Related]
17. Advanced ovarian cancer: a clinical update on first-line treatment, recurrent disease, and new agents.
Ozols RF
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S60-73. PubMed ID: 19780247
[TBL] [Abstract][Full Text] [Related]
18. Intraperitoneal chemotherapy for ovarian cancer.
Hamilton CA; Berek JS
Curr Opin Oncol; 2006 Sep; 18(5):507-15. PubMed ID: 16894301
[TBL] [Abstract][Full Text] [Related]
19. Anticancer Drug Development: The Way Forward.
Connors T
Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
[TBL] [Abstract][Full Text] [Related]
20. Intraperitoneal cisplatin and carboplatin in the management of ovarian cancer.
Markman M
Semin Oncol; 1994 Apr; 21(2 Suppl 2):17-9; quiz 20, 58. PubMed ID: 8202717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
